Scholars
Kathrin Lauber
University of Edinburgh
Based in
United Kingdom
Europe
Kathrin is a postdoctoral researcher interested in commercial influence and the role of evidence and ideas in policymaking, as well as the ways in which governance infrastructure shapes these dynamics. Food policy has been a primary focus of her research to date, and she has a special interest in advertising regulation as a policy instrument to address climate and health harms. Kathrin has also advised the World Health Organization and various non-governmental organisations on issues such as sugar-sweetened beverage taxation, advertising regulation, and conflict of interest management.
![](https://cssn.org/wp-content/uploads/2024/07/Lauber_Headshot.jpg)
Country(ies) of Specialty
Focus areas of expertise
Climate policy and politics AgriculturePublications
Articles
Eleanor Brooks & Kathrin Lauber. 2024. “Administering a Chill Pill? Better Regulation and the Potential for Regulatory Chill in European Union Health Policy“. Journal of Health Politics, Policy and Law.
Kathrin Lauber & Eleanor Brooks. 2023. “Why meta-regulation matters for public health: the case of the EU better regulation agenda“. Globalisation & Health.
Karen Evans-Reeves, Kathrin Lauber, & Rosemary Hiscock. 2022. “The ‘filter fraud’ persists: The tobacco industry is still using filters to suggest lower health risks while destroying the environment“. Tobacco Control.
Kathrin Lauber, Daniel Hunt, Anna B. Gilmore, & Harry Rutter. 2021. “Corporate political activity in the context of unhealthy food advertising restrictions across Transport for London: A qualitative case study“. PLoS Medicine.
Kathrin Lauber, Darragh McGee, & Anna B Gilmore. 2021. “Commercial use of evidence in public health policy: a critical assessment of food industry submissions to global-level consultations on non-communicable disease prevention“. BMJ Global Health.
Kathrin Lauber, Harry Rutter, Anna B Gilmore. 2021. “Big food and the World Health Organization: A qualitative study of industry attempts to influence global-level non-communicable disease policy“.BMJ Global Health.